The Sanger Institute and Mission Bio will be holding a single-cell technology seminar. Single-cell sequencing methods have enabled multi-modal characterization of tumor heterogeneity, and yielded novel insights into tumor evolution, therapeutic response & resistance, and minimal residual disease (MRD). Join us for an overview of the Tapestri Platform, and the novel capability to co-detect SNVs, CNVs, and immunophenotype from the same cell with a single, high-throughput workflow. The webinar will cover:
-Mission Bio technology overview
-Applications: targeted SNV, CNV and protein for single-cell analysis
-Oncology – clonal analysis in translational oncology research in solid tumor and hematology
-Q&A
